Senior insider sale
EVP, Research & Development at JAZZ PHARMACEUTICALS PLC — senior position signals high conviction
$19.21M
76.92K shares
What this filing means
IANNONE ROBERT plans to sell 76.92K shares of JAZZ PHARMACEUTICALS PLC valued at approximately $19.21M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/27/2026ACC: 0001950047-26-008785
Officer· EVP, Research & Development
Since May 2019
76.92K
Shares to sell
$19.21M
Approx. market value
76.92K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months4
Stock Option Exercise
Cash
8/27/2026
55.79KRestricted Stock
Not Applicable
3/5/2026
13.50KPerformance Shares
Not Applicable
1/16/2026
7.56KEmployee Stock Purchase Plan
Cash
11/28/2025
71.00Total acquired76.92K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/27/2026 | Stock Option Exercise Cash | 55.79K | — |
3/5/2026 | Restricted Stock Not Applicable | 13.50K | — |
1/16/2026 | Performance Shares Not Applicable | 7.56K | — |
11/28/2025 | Employee Stock Purchase Plan Cash | 71.00 | — |
| Total | 76.92K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
76.92K
Market value
$19.21M
8/27/2026
Total
Units
76.92K
Value
$19.21M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/27/2026 | 76.92K | $19.21M | NASDAQ | Planned |
| Total | 76.92K | $19.21M | ||